Literature DB >> 17579309

The use of knee-length versus thigh-length compression stockings and sequential compression devices.

Debra Brady1, Bonnie Raingruber, Janet Peterson, Winifred Varnau, James Denman, Raquel Resuello, Roumelia De Contreaus, Jaime Mahnke.   

Abstract

BACKGROUND: Nurses on an Acute Care Evidence Based Practice Committee, creating a policy to increase patient compliance with thromboembolic deterrent stockings (TEDS) and sequential compression devices (SCDs) for deep vein thrombosis prophylaxis, found limited literature on patient preference and response to this treatment. STUDY AIM: The study purpose was to determine whether knee-length or thigh-length TEDS and/or SCDs were more comfortable, correctly applied, and worn by patients, and to assess patient reasons for noncompliance.
METHOD: A patient survey and observational data tool was designed. Six surveyors collected data (interrater reliability = 93%) from 137 randomly selected patients with orders for TEDS and/or SCDs admitted to acute care medical or surgical nursing units.
RESULTS: Most patients wore thigh-length SCDs and TEDS. However, only 29.2% (n = 40) had SCDs on them at the time of survey, and 62.8% (n = 86) were compliant with TEDS. The most common reasons given for noncompliance with SCDs were that the devices were not reapplied after bathing or ambulating, or were removed because they were hot or itchy. Complaints of discomfort were highest among patients wearing thigh-length SCDs and TEDS. Problems with fit were 50% higher in those who wore thigh-length TEDS, and involved stockings that created restricting bands. Most patients understood the purpose of treatment, and older patients were more compliant than younger patients. IMPLICATIONS FOR PRACTICE: Knee-length TEDS and SCDs are more comfortable for patients, encourage higher levels of compliance with treatment, do not pose a risk for venous stasis to patients by creating restricting bands, and are less expensive. Patients need ongoing education to resume wearing TEDS and SCDs after activities of daily living, and knee-length stockings and devices would be easier to reapply. The policy in our institution was changed for the use of knee-length compression stockings and SCDs.

Entities:  

Mesh:

Year:  2007        PMID: 17579309     DOI: 10.1097/01.CNQ.0000278926.67562.2f

Source DB:  PubMed          Journal:  Crit Care Nurs Q        ISSN: 0887-9303


  5 in total

Review 1.  Use graduated compression stockings postoperatively to prevent deep vein thrombosis.

Authors:  Susan M Phillips; Martin Gallagher; Heather Buchan
Journal:  BMJ       Date:  2008-04-26

2.  Prevention of Venous Thromboembolism in Individuals with Spinal Cord Injury: Clinical Practice Guidelines for Health Care Providers, 3rd ed.: Consortium for Spinal Cord Medicine.

Authors: 
Journal:  Top Spinal Cord Inj Rehabil       Date:  2016

3.  Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines.

Authors:  Itziar Etxeandia-Ikobaltzeta; Yuan Zhang; Francesca Brundisini; Ivan D Florez; Wojtek Wiercioch; Robby Nieuwlaat; Housne Begum; Carlos A Cuello; Yetiani Roldan; Ru Chen; Chengyi Ding; Rebecca L Morgan; John J Riva; Yuqing Zhang; Rana Charide; Arnav Agarwal; Sara Balduzzi; Gian Paolo Morgano; Juan José Yepes-Nuñez; Yasir Rehman; Ignacio Neumann; Nicole Schwab; Tejan Baldeh; Cody Braun; María Francisca Rodríguez; Holger J Schünemann
Journal:  Blood Adv       Date:  2020-03-10

4.  Intermittent pneumatic compression for venous thromboembolism prevention: a systematic review on factors affecting adherence.

Authors:  Richard Greenall; Rachel E Davis
Journal:  BMJ Open       Date:  2020-09-03       Impact factor: 2.692

Review 5.  Thigh length versus knee length antiembolism stockings for the prevention of deep vein thrombosis in postoperative surgical patients; a systematic review and network meta-analysis.

Authors:  Ros Wade; Fiona Paton; Stephen Rice; Gerard Stansby; Peter Millner; Hayley Flavell; Dave Fox; Nerys Woolacott
Journal:  BMJ Open       Date:  2016-02-16       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.